Last update:
Coronavirus (COVID-19)
Medical research
Comprehensive COVID-19 database shows promise for future pandemics
COVID-19 may seem well and truly in the past, but another deadly pandemic is a question of "when," not "if." To help prevent mass deaths and other harms, like deteriorating mental health and economic downfall, a Swinburne ...
Jun 24, 2025
0
86
Diseases, Conditions, Syndromes
Researchers discover protein necessary for SARS-CoV-2 to evade the body's defenses
The human body is naturally equipped with defenses to fight off viral infections. For a virus to successfully infect it, it must first overcome these defenses. To do so, viruses have evolved specialized tools—proteins known ...
Jun 12, 2025
0
45
COVID-19 outbreak
Coronavirus disease 2019 (COVID-19) is the infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
A pneumonia of unknown cause detected in Wuhan, China was first reported to the World Health Organization Country Office in China on 31 December 2019 and recognised as a pandemic on 11 March 2020.
Reported illnesses have ranged from mild symptoms to severe illness and death for confirmed COVID-19 cases.
More information: WHO, CDC, global cases.
Follow us on Google News for the latest updates on the coronavirus.
Broad-spectrum coronavirus drug developed through AI-enabled dynamic modeling
About 30% of all respiratory tract infections are caused by coronaviruses, leading to widespread illnesses and, in some cases, to epidemic and even pandemic outbreaks, as we experienced with the COVID-19 pandemic. Despite ...
Jun 12, 2025
0
0
Llama-derived antibodies target coronaviruses' conserved spike region, offering broad protection
Scientists have discovered a unique class of small antibodies that are strongly protective against a wide range of SARS coronaviruses, including SARS-CoV-1 and numerous early and recent SARS-CoV-2 variants. The unique antibodies ...
Jun 11, 2025
0
36
CRISPR-Cas13 allows selective modification of desired RNA in living cells
RNA gene scissors (CRISPR-Cas13) are gaining significant attention as a next-generation gene therapy with fewer side effects. They can suppress infection by eliminating viral RNA, such as in coronaviruses, or regulate the ...
Jun 10, 2025
0
67
New AI tool reimagines infectious disease forecasting, outperforms existing state-of-the-art methods
An AI tool, created by researchers at Johns Hopkins and Duke universities, could revolutionize how public health officials predict, track and manage outbreaks of infectious diseases including flu and COVID-19.
Jun 6, 2025
0
36
Critical step in COVID-19 infection identified—how the virus shields itself during replication
Researchers at Texas Biomedical Research Institute and the University of Chicago have uncovered a mechanism that SARS-CoV-2, the virus that causes COVID-19, uses to protect itself inside the body as it works to replicate ...
Jun 5, 2025
0
32
Fighting poultry disease with mRNA: Researchers pioneer nanoparticle approach
Researchers from UConn's College of Agriculture, Health and Natural Resources (CAHNR) and College of Liberal Arts and Sciences (CLAS) have demonstrated that a novel protein-based nanoparticle can make mRNA vaccines more effective ...
Jun 5, 2025
0
9
Bat viruses similar to MERS have potential to jump to humans
A group of bat viruses closely related to the deadly Middle East respiratory syndrome coronavirus (MERS-CoV) could be one small mutation away from being capable of spilling over into human populations and potentially causing ...
Jun 4, 2025
0
6
Study shows infant immune systems respond differently to severe COVID-19
Infants hospitalized with severe COVID-19 have significantly different immune responses than adults or older children. The finding comes from scientists at St. Jude Children's Research Hospital, The Jackson Laboratory for ...
May 16, 2025
0
41
New study offers insights into designing safe, effective nasal vaccines
Most vaccines—and boosters—are injected directly into muscle tissue, usually in the upper arm, to kickstart the body's immune system in the fight against disease. But for respiratory diseases like COVID-19, it can be ...
May 13, 2025
0
107
Scientists reveal crystal structure of protein that allows viruses to infect cells in human airway
New research by scientists at the University of Toronto and the Structural Genomics Consortium has deepened our understanding of how viruses like the flu, common cold, and COVID-19 get into cells in human airways.
May 13, 2025
0
116
Bat virus evolution suggests wildlife trade sparked COVID-19 virus emergence in humans
The ancestor of the virus that causes COVID-19 left its point of origin in Western China or Northern Laos just several years before the disease first emerged in humans up to 2,700 kilometers away in Central China, according ...
May 7, 2025
2
53
WHO says all COVID-19 origin theories still open, after inconclusive study
All hypotheses on how the COVID-19 pandemic began remain open, the World Health Organization said Friday, following an inconclusive four-year investigation that was hamstrung by crucial information being withheld.
Jun 27, 2025
0
0
COVID 'razor blade throat' rises as new subvariant spreads in California
COVID-19 appears to be on the rise in some parts of California as a new, highly contagious subvariant—featuring "razor blade throat" symptoms overseas—is becoming increasingly dominant.
Jun 17, 2025
0
1
Geographic bias in virus naming: Lessons from coronavirus show it's better to act early
"China virus," the Chinese virus—at the start of the 2020 pandemic, this epithet was often encountered in the media. The use of geographically based labels to define the disease (COVID-19) and the virus causing it (SARS-CoV-2) ...
Jun 13, 2025
2
0
Germany's BioNTech to buy CureVac to boost cancer research
Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, the companies said Thursday, bringing together two pharmaceutical firms specialized in mRNA technology with the goal of advancing cancer treatments.
Jun 12, 2025
0
0
Migrant status compounds inequality for ethnic minority NHS staff, study finds
Ethnic minority health care workers who are also born overseas face a double disadvantage due to the combined effects of ethnicity and migrant status, according to research published in JRSM Open.
Jun 10, 2025
0
0
Moderna's new lower-dose COVID-19 vaccine approved by FDA
The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.
Jun 4, 2025
0
0
A new COVID subvariant spreads rapidly as Trump pivots away from vaccines
A new, highly transmissible COVID subvariant has been detected in California—heightening the risk of a potential summer wave as recent moves by the Trump administration threaten to make vaccines harder to get, and more ...
Jun 2, 2025
0
6
